Literature DB >> 27157044

Paraneoplastic stiff person syndrome: Inpatient rehabilitation outcomes of a rare disease from two cancer rehabilitation programmes.

Sean Robinson Smith1, Jack B Fu.   

Abstract

Paraneoplastic stiff person syndrome is a rare, but debilitating, manifestation of cancer, characterized by painful extremities, truncal and facial spasms. The resultant functional impairment may necessitate comprehensive rehabilitation and symptom management. This case series describes the acute inpatient rehabilitation courses of 2 patients at different tertiary care referral cancer rehabilitation programmes, including work-up and diagnosis, medical management of symptoms, and functional outcomes. Both patients had a reduction in symptom burden and an improvement in motor function as a result of multidisciplinary acute inpatient rehabilitation.

Entities:  

Mesh:

Year:  2016        PMID: 27157044     DOI: 10.2340/16501977-2089

Source DB:  PubMed          Journal:  J Rehabil Med        ISSN: 1650-1977            Impact factor:   2.912


  4 in total

1.  Stiff Person Syndrome: A Case Report with Sudden Onset and Coexistence of Sero-Positive Antibodies to Glutamic Acid Decarboxylase and Anti-SOX1 Antibodies.

Authors:  Phuong Minh Nguyen; Dung Duy Vu; Kien Dung Vu; Hai Thanh Nguyen; Dinh Van Nguyen
Journal:  Case Rep Neurol       Date:  2022-05-10

2.  Stiff-person syndrome with paraneoplastic neurological syndrome: a case report and literature review.

Authors:  Hanwen Zhang; Wenshi Wei
Journal:  Am J Transl Res       Date:  2022-02-15       Impact factor: 4.060

Review 3.  The Intersection of Oncology Prognosis and Cancer Rehabilitation.

Authors:  Sean Robinson Smith; Jasmine Yiqian Zheng
Journal:  Curr Phys Med Rehabil Rep       Date:  2017-03-01

4.  Paraneoplastic Stiff Person Syndrome in Early-Stage Breast Cancer with Positive Anti-Amphiphysin Antibodies.

Authors:  Vitalie Vacaras; Enia Eleonora Cucu; Roxana Radu; Dafin Fior Muresanu
Journal:  Case Rep Neurol       Date:  2020-10-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.